Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2018

07.02.2018 | Glaucoma

The effect of trabeculectomy on serum brain-derived neurotrophic factor levels in primary open-angle glaucoma

verfasst von: Mehmet Murat Uzel, Ufuk Elgin, Barış Boral, Muharrem Çiçek, Emine Şen, Burçin Şener, Pelin Yılmazbaş

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 6/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We aimed to investigate the effect of trabeculectomy on serum brain-derived neurotrophic factor (BDNF) levels. Our secondary goal was to compare serum and aqueous humor (AH) BDNF levels in primary open-angle glaucoma (POAG) and control subjects.

Methods

This prospective, cross-sectional study consists of 20 eyes of with advanced-stage POAG who had trabeculectomy and 19 eyes of age- and sex-matched control healthy subjects who had cataract surgery. Serum and AH samples were obtained preoperatively in trabeculectomy group and control subjects. Serum samples were obtained at the third postoperative month in both groups.

Results

The aqueous humor and serum levels of BDNF at the surgery day were found to be strongly positive correlated (r = 0.868; p < 0.001). Serum and AH BDNF levels of POAG cases were significantly lower than control subjects at the surgery day (respectively p = 0.038, p = 0.011). In POAG cases, serum BDNF levels significantly increased at the third month after trabeculectomy while there was not a significant difference in control subjects with cataract surgery (p < 0.001; p = 0.717 respectively).

Conclusion

Trabeculectomy was found to have a positive effect on serum BDNF levels in POAG cases.
Literatur
1.
Zurück zum Zitat Chang EE, Goldberg (2012) JLGlaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119:979–986 Chang EE, Goldberg (2012) JLGlaucoma 2.0: neuroprotection, neuroregeneration, neuroenhancement. Ophthalmology 119:979–986
2.
Zurück zum Zitat Miglior S, Bertuzzi F (2013) Relationship between intraocular pressure and glaucoma onset and progression. Curr Opin Pharmacol 13:32–35CrossRefPubMed Miglior S, Bertuzzi F (2013) Relationship between intraocular pressure and glaucoma onset and progression. Curr Opin Pharmacol 13:32–35CrossRefPubMed
3.
Zurück zum Zitat Smith MA, Xia CZ, Dengler-Crish CM, Fening KM, Inman DM, Schofield BR, Crish SD (2016) Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma. J Comp Neurol 1(524):3503–3517CrossRef Smith MA, Xia CZ, Dengler-Crish CM, Fening KM, Inman DM, Schofield BR, Crish SD (2016) Persistence of intact retinal ganglion cell terminals after axonal transport loss in the DBA/2J mouse model of glaucoma. J Comp Neurol 1(524):3503–3517CrossRef
4.
Zurück zum Zitat Fahy ET, Chrysostomou V, Abbott CJ, van Wijngaarden P, Crowston JG (2016) Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury. Exp Eye Res 146:289–292CrossRefPubMed Fahy ET, Chrysostomou V, Abbott CJ, van Wijngaarden P, Crowston JG (2016) Axonal transport along retinal ganglion cells is grossly intact during reduced function post-injury. Exp Eye Res 146:289–292CrossRefPubMed
5.
Zurück zum Zitat Johnson TV, Bull ND, Martin KR (2011) Neurotrophic factor delivery as a protective treatment for glaucoma. Exp Eye Res 93:196–203CrossRefPubMed Johnson TV, Bull ND, Martin KR (2011) Neurotrophic factor delivery as a protective treatment for glaucoma. Exp Eye Res 93:196–203CrossRefPubMed
6.
Zurück zum Zitat Feng L, Chen H, Yi J, Troy JB, Zhang HF, Liu X (2016) Long-term protection of retinal ganglion cells and visual function by brain-derived neurotrophic factor in mice with ocular hypertension. Invest Ophthalmol Vis Sci 57:3793–3802CrossRefPubMedPubMedCentral Feng L, Chen H, Yi J, Troy JB, Zhang HF, Liu X (2016) Long-term protection of retinal ganglion cells and visual function by brain-derived neurotrophic factor in mice with ocular hypertension. Invest Ophthalmol Vis Sci 57:3793–3802CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ghaffariyeh A, Honarpisheh N, Heidari MH, Puyan S, Abasov F (2011) Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma. Optom Vis Sci 88:80–85CrossRefPubMed Ghaffariyeh A, Honarpisheh N, Heidari MH, Puyan S, Abasov F (2011) Brain-derived neurotrophic factor as a biomarker in primary open-angle glaucoma. Optom Vis Sci 88:80–85CrossRefPubMed
8.
Zurück zum Zitat Schehlein EM, Novack GD, Robin AL (2017) New classes of glaucoma medications. Curr Opin Ophthalmol 28:161–168PubMed Schehlein EM, Novack GD, Robin AL (2017) New classes of glaucoma medications. Curr Opin Ophthalmol 28:161–168PubMed
9.
Zurück zum Zitat Vinod K, Gedde SJ (2017) Clinical investigation of new glaucoma procedures. Curr Opin Ophthalmol 28:187–193PubMed Vinod K, Gedde SJ (2017) Clinical investigation of new glaucoma procedures. Curr Opin Ophthalmol 28:187–193PubMed
10.
Zurück zum Zitat Sawchyn AK, Slabaugh MA (2016) Innovations and adaptations in trabeculectomy. Curr Opin Ophthalmol 27:158–163CrossRefPubMed Sawchyn AK, Slabaugh MA (2016) Innovations and adaptations in trabeculectomy. Curr Opin Ophthalmol 27:158–163CrossRefPubMed
11.
Zurück zum Zitat Wittström E, Schatz P, Lövestam-Adrian M, Ponjavic V, Bergström A, Andréasson S (2010) Improved retinal function after trabeculectomy in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 248:485–495CrossRefPubMed Wittström E, Schatz P, Lövestam-Adrian M, Ponjavic V, Bergström A, Andréasson S (2010) Improved retinal function after trabeculectomy in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 248:485–495CrossRefPubMed
12.
Zurück zum Zitat Magacho L, Henderer JD, Lankaranian D, Steinmann WC, Spaeth GL (2006) Improvement in colour vision parameters following successful trabeculectomy. Acta Ophthalmol Scand 84:201–205CrossRefPubMed Magacho L, Henderer JD, Lankaranian D, Steinmann WC, Spaeth GL (2006) Improvement in colour vision parameters following successful trabeculectomy. Acta Ophthalmol Scand 84:201–205CrossRefPubMed
13.
Zurück zum Zitat Caprioli J, de Leon JM, Azarbod P, Chen A, Morales E, Nouri-Mahdavi K, Coleman A, Yu F, Afifi A (2016) Trabeculectomy can improve long-term visual function in glaucoma. Ophthalmology 123:117–128CrossRefPubMed Caprioli J, de Leon JM, Azarbod P, Chen A, Morales E, Nouri-Mahdavi K, Coleman A, Yu F, Afifi A (2016) Trabeculectomy can improve long-term visual function in glaucoma. Ophthalmology 123:117–128CrossRefPubMed
14.
Zurück zum Zitat Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, Kerrigan DF, Mitchell RS (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 41:3460–3466PubMed Quigley HA, McKinnon SJ, Zack DJ, Pease ME, Kerrigan-Baumrind LA, Kerrigan DF, Mitchell RS (2000) Retrograde axonal transport of BDNF in retinal ganglion cells is blocked by acute IOP elevation in rats. Invest Ophthalmol Vis Sci 41:3460–3466PubMed
15.
Zurück zum Zitat Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41:764–774PubMed Pease ME, McKinnon SJ, Quigley HA, Kerrigan-Baumrind LA, Zack DJ (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci 41:764–774PubMed
16.
Zurück zum Zitat The Advanced Glaucoma Intervention Study Investigators (1994) Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 101(8):1445–1455CrossRef The Advanced Glaucoma Intervention Study Investigators (1994) Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 101(8):1445–1455CrossRef
17.
Zurück zum Zitat Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912–918CrossRefPubMed Takihara Y, Inatani M, Fukushima M, Iwao K, Iwao M, Tanihara H (2009) Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 147:912–918CrossRefPubMed
18.
Zurück zum Zitat Harper MM, Grozdanic SD, Blits B, Kuehn MH, Zamzow D, Buss JE, Kardon RH, Sakaguchi DS (2011) Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes. Invest Ophthalmol Vis Sci 23(52):4506–4515CrossRef Harper MM, Grozdanic SD, Blits B, Kuehn MH, Zamzow D, Buss JE, Kardon RH, Sakaguchi DS (2011) Transplantation of BDNF-secreting mesenchymal stem cells provides neuroprotection in chronically hypertensive rat eyes. Invest Ophthalmol Vis Sci 23(52):4506–4515CrossRef
19.
Zurück zum Zitat Oddone F, Roberti G, Micera A, Busanello A, Bonini S, Quaranta L, Agnifili L, Manni G (2017) Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages. PLoS One. 9 12(1):e0168565CrossRef Oddone F, Roberti G, Micera A, Busanello A, Bonini S, Quaranta L, Agnifili L, Manni G (2017) Exploring serum levels of brain derived neurotrophic factor and nerve growth factor across glaucoma stages. PLoS One. 9 12(1):e0168565CrossRef
20.
Zurück zum Zitat Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553–1561CrossRefPubMed Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553–1561CrossRefPubMed
21.
Zurück zum Zitat Herzog KH, von Bartheld CS (1998) Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J Neurosci 18:2891–2906CrossRefPubMed Herzog KH, von Bartheld CS (1998) Contributions of the optic tectum and the retina as sources of brain-derived neurotrophic factor for retinal ganglion cells in the chick embryo. J Neurosci 18:2891–2906CrossRefPubMed
22.
Zurück zum Zitat Ghaffariyeh A, Honarpisheh N, Shakiba Y, Puyan S, Chamacham T, Zahedi F, Zarrineghbal M (2009) Brain-derived neurotrophic factor in patients with normal-tension glaucoma. Optometry 80:635–638CrossRefPubMed Ghaffariyeh A, Honarpisheh N, Shakiba Y, Puyan S, Chamacham T, Zahedi F, Zarrineghbal M (2009) Brain-derived neurotrophic factor in patients with normal-tension glaucoma. Optometry 80:635–638CrossRefPubMed
23.
Zurück zum Zitat Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123CrossRefPubMed Lommatzsch M, Zingler D, Schuhbaeck K, Schloetcke K, Zingler C, Schuff-Werner P, Virchow JC (2005) The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging 26:115–123CrossRefPubMed
24.
Zurück zum Zitat Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz Z, Koehler N, Bartels M, Buchkremer G, Schott K (2007) BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41:387–394CrossRefPubMed Laske C, Stransky E, Leyhe T, Eschweiler GW, Maetzler W, Wittorf A, Soekadar S, Richartz Z, Koehler N, Bartels M, Buchkremer G, Schott K (2007) BDNF serum and CSF concentrations in Alzheimer’s disease, normal pressure hydrocephalus and healthy controls. J Psychiatr Res 41:387–394CrossRefPubMed
25.
Zurück zum Zitat Azoulay D, Urshansky N, Karni A (2008) Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol 195:186–193CrossRefPubMed Azoulay D, Urshansky N, Karni A (2008) Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. J Neuroimmunol 195:186–193CrossRefPubMed
26.
Zurück zum Zitat Goldshtein I, Shalev V, Zigman N, Chodick G, Levkovitch-Verbin H (2016) The Maccabi Glaucoma Study: treatment patterns and persistence with glaucoma therapy in a large Israeli health maintenance organization. J Glaucoma 25(4):e386–e391CrossRefPubMed Goldshtein I, Shalev V, Zigman N, Chodick G, Levkovitch-Verbin H (2016) The Maccabi Glaucoma Study: treatment patterns and persistence with glaucoma therapy in a large Israeli health maintenance organization. J Glaucoma 25(4):e386–e391CrossRefPubMed
Metadaten
Titel
The effect of trabeculectomy on serum brain-derived neurotrophic factor levels in primary open-angle glaucoma
verfasst von
Mehmet Murat Uzel
Ufuk Elgin
Barış Boral
Muharrem Çiçek
Emine Şen
Burçin Şener
Pelin Yılmazbaş
Publikationsdatum
07.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 6/2018
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3923-y

Weitere Artikel der Ausgabe 6/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2018 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.